The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.

Recruiting now

Conditions studied: Lung Cancer, Esophageal Cancer

In brief

This study aims to assess the level of participation of thoracic cancer patients undergoing definitive radiotherapy and chemotherapy ± immunotherapy in their medical processes and the association between the level of participation and patients' side effects, quality of life, and long-term survival. Additionally, this study will rate the level of participation from both the patients' and medical staff's perspectives and will compare the differences in ratings from these two viewpoints, as well as their impact on treatment outcomes.

Key facts

Study ID

NCT06019455

Run by

Sun Yat-sen University

People needed

500

Starts

2022-06-01

Expected to finish

2027-05-30

Last updated by the study team

2024-12-10

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Locally advanced non-small cell lung cancer, limited-stage small cell lung cancer, and esophageal cancer.
• Planned to undergo definitive chemoradiotherapy ± immunotherapy;
• Males or females aged 18 to 75;
• Able to communicate with medical staff.
• Exclusion Criteria: Patients with cognitive impairments.

Where it is running

• Sun Yat-sen University — Guangzhou, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.